HomeKNE • CVE
add
Kane Biotech Inc
Previous close
$0.040
Day range
$0.040 - $0.045
Year range
$0.035 - $0.14
Market cap
6.64M CAD
Avg Volume
112.39K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 28.00K | -95.49% |
Operating expense | 229.93K | -84.29% |
Net income | -348.54K | -103.79% |
Net profit margin | -1.24K | -183.94% |
Earnings per share | — | — |
EBITDA | -229.13K | 78.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.61M | 59.71% |
Total assets | 3.81M | -6.45% |
Total liabilities | 4.05M | -15.63% |
Total equity | -234.99K | — |
Shares outstanding | 166.23M | — |
Price to book | ∞ | — |
Return on assets | -20.97% | — |
Return on capital | -41.86% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -348.54K | -103.79% |
Cash from operations | -772.90K | 64.37% |
Cash from investing | -40.80K | -100.45% |
Cash from financing | 1.93M | 125.54% |
Net change in cash | 1.12M | 261.32% |
Free cash flow | -825.02K | 47.57% |
About
Founded
2001
Headquarters
Website
